Art

J-GLOBAL ID：201202209311944570   Reference number：12A1670586

Anti-arrhythmic device therapy has limits in improving the prognosis of patients with cardiac amyloidosis

抗不整脈デバイス治療は心アミロイドーシス患者の予後改善に限界がある

Author (14)： KOJIMA Toshiya (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  IMAI Yasushi (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  FUJIU Katsuhito (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  FUJIU Katsuhito (Translational Systems Biology and Medicine Initiative, The Univ. of Tokyo Graduate School of Medicine) ,  SUZUKI Takeki (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  SUGIYAMA Hiroaki (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  ASADA Kazuo (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  AJIKI Kohsuke (Cardiovascular Center, JR Tokyo General Hospital) ,  HAYAMI Noriyuki (Fourth Dep. of Internal Medicine, Teikyo Univ. School of Medicine) ,  MURAKAWA Yuji (Fourth Dep. of Internal Medicine, Teikyo Univ. School of Medicine) ,  NAGAI Ryozo (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  NAGAI Ryozo (Translational Systems Biology and Medicine Initiative, The Univ. of Tokyo Graduate School of Medicine) ,  NAGAI Ryozo (Global COE, The Univ. of Tokyo Graduate School of Medicine) ,  NAGAI Ryozo (Translational Res. Center, The Univ. of Tokyo Graduate School of Medicine)
Material： Journal of Arrhythmia  (J Arrhythmia)
Volume： 28  Issue： 4  Page： 242-246 (J-STAGE)  Publication year： 2012 
JST Material Number： Y0127A  ISSN： 1880-4276  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *Amyloidosis ,...
Semi thesaurus term： AL amyloidosis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A1670586&from=J-GLOBAL&jstjournalNo=Y0127A") }}

JST classification (2)： Medical instruments and apparatuses  (GA05020L) ,  Treatment for cardiovasular system diseases in general  (GJ05010B)

Reference (18)：

• [1] Dubrey SW, Cha K, Anderson J, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. Q J Math 1998;91:141-157.
• [2] Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med 2000;45:107-137.
• [3] Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983;58:665-683.
• [4] Cohen AS, Rubinow A, Anderson JJ, et al. Survival of patients with primary (AL) amyloidosis. colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973). Am J Med 1987;82:1182-1190.
• [5] Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997;336:1202-1207.

Terms in the title (5)： 不整脈 ,  治療 ,  心アミロイドーシス ,  患者の予後 ,  限界